144 related articles for article (PubMed ID: 35802851)
41. Beyond transanal total mesorectal excision: short-term outcomes of transanal total mesorectal excision in locally advanced rectal cancer requiring resection beyond total mesorectal excision.
Larach JT; Rajkomar AKS; Smart PJ; McCormick JJ; Heriot AG; Warrier SK
Colorectal Dis; 2021 Apr; 23(4):823-833. PubMed ID: 33217140
[TBL] [Abstract][Full Text] [Related]
42. Simple instruments facilitating achievement of transanal total mesorectal excision in male patients.
Xu C; Song HY; Han SL; Ni SC; Zhang HX; Xing CG
World J Gastroenterol; 2017 Aug; 23(31):5798-5808. PubMed ID: 28883706
[TBL] [Abstract][Full Text] [Related]
43. Effect of transanal total mesorectal excision for rectal cancer: comparison of short-term outcomes with laparoscopic and open surgeries.
Perdawood SK; Thinggaard BS; Bjoern MX
Surg Endosc; 2018 May; 32(5):2312-2321. PubMed ID: 29098433
[TBL] [Abstract][Full Text] [Related]
44. Functional outcomes after resections for low rectal tumors: comparison of Transanal with laparoscopic Total Mesorectal excision.
Rubinkiewicz M; Zarzycki P; Witowski J; Pisarska M; Gajewska N; Torbicz G; Nowakowski M; Major P; Budzyński A; Pędziwiatr M
BMC Surg; 2019 Jul; 19(1):79. PubMed ID: 31277628
[TBL] [Abstract][Full Text] [Related]
45. Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer.
Rasulov AO; Mamedli ZZ; Gordeyev SS; Kozlov NA; Dzhumabaev HE
Tech Coloproctol; 2016 Apr; 20(4):227-34. PubMed ID: 26794213
[TBL] [Abstract][Full Text] [Related]
46. Phase II Clinical Trial to Evaluate the Efficacy of Transanal Endoscopic Total Mesorectal Excision for Rectal Cancer.
Park SC; Sohn DK; Kim MJ; Chang HJ; Han KS; Hyun JH; Joo J; Oh JH
Dis Colon Rectum; 2018 May; 61(5):554-560. PubMed ID: 29624549
[TBL] [Abstract][Full Text] [Related]
47. Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer.
Marks JH; Myers EA; Zeger EL; Denittis AS; Gummadi M; Marks GJ
Surg Endosc; 2017 Dec; 31(12):5248-5257. PubMed ID: 28643051
[TBL] [Abstract][Full Text] [Related]
48. [Application of transanal total mesorectal excision in radical surgery for rectal cancer].
He L; Xiao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Aug; 20(8):957-960. PubMed ID: 28836258
[TBL] [Abstract][Full Text] [Related]
49. The Essence of Transanal Total Mesorectal Excision: In Reply to Yuksel.
Matsuda T; Kakeji Y
J Am Coll Surg; 2023 Aug; 237(2):396. PubMed ID: 37158472
[No Abstract] [Full Text] [Related]
50. Transanal total mesorectal excision assisted by single-port laparoscopic surgery for low rectal cancer.
Chen WH; Kang L; Luo SL; Zhang XW; Huang Y; Liu ZH; Wang JP
Tech Coloproctol; 2015 Sep; 19(9):527-34. PubMed ID: 26220109
[TBL] [Abstract][Full Text] [Related]
51. Transanal (TaTME) vs. laparoscopic total mesorectal excision for mid and low rectal cancer: a propensity score-matched analysis of early and long-term outcomes.
Munini M; Popeskou SG; Galetti K; Roesel R; Mongelli F; Christoforidis D
Int J Colorectal Dis; 2021 Oct; 36(10):2271-2279. PubMed ID: 34467413
[TBL] [Abstract][Full Text] [Related]
52. Transanal total mesorectal excision for treating a lower rectal inflammatory myofibroblastic tumor: A case report.
Narihiro S; Teramura K; Kitaguchi D; Ikeda K; Hasegawa H; Tsukada Y; Nishizawa Y; Ito M
Asian J Endosc Surg; 2022 Oct; 15(4):841-845. PubMed ID: 35665471
[TBL] [Abstract][Full Text] [Related]
53. Short- and long-term outcomes of transanal versus laparoscopic total mesorectal excision for mid-to-low rectal cancer: a meta-analysis.
Zhang X; Gao Y; Dai X; Zhang H; Shang Z; Cai X; Shen T; Cheng X; Yu K; Li Y
Surg Endosc; 2019 Mar; 33(3):972-985. PubMed ID: 30374790
[TBL] [Abstract][Full Text] [Related]
54. Comparison of short-term efficacy of transanal total mesorectal excision and laparoscopic total mesorectal excision in low rectal cancer.
Ren J; Liu S; Luo H; Wang B; Wu F
Asian J Surg; 2021 Jan; 44(1):181-185. PubMed ID: 32461015
[TBL] [Abstract][Full Text] [Related]
55. Laparoscopic sphincter-preserving total pelvic exenteration with transanal total mesorectal excision for locally advanced rectal cancer-A video vignette.
Seow-En I; Tan YG; Tay KJ
Colorectal Dis; 2022 Apr; 24(4):542-543. PubMed ID: 34856065
[No Abstract] [Full Text] [Related]
56. Technological Advances in the Surgical Treatment of Colorectal Cancer.
Hahn SJ; Sylla P
Surg Oncol Clin N Am; 2022 Apr; 31(2):183-218. PubMed ID: 35351273
[TBL] [Abstract][Full Text] [Related]
57. Robotic or transanal total mesorectal excision (TaTME) approach for rectal cancer, how about both? Feasibility and outcomes from a single institution.
Inoue Y; Ng JY; Chu CH; Lai YL; Huang IP; Yang SH; Chen CC
J Robot Surg; 2022 Feb; 16(1):149-157. PubMed ID: 33704671
[TBL] [Abstract][Full Text] [Related]
58. The role of transanal total mesorectal excision.
Rutgers MLW; Bemelman WA; Khan JS; Hompes R
Surg Oncol; 2022 Aug; 43():101695. PubMed ID: 34924223
[TBL] [Abstract][Full Text] [Related]
59. Robotic transanal total mesorectal excision combined with intersphincteric resection for ultra-low rectal cancer.
Li F; Zhang F; Tan D; Ye J; Tong W
Tech Coloproctol; 2021 Dec; 25(12):1335-1336. PubMed ID: 34236533
[No Abstract] [Full Text] [Related]
60. Transanal Total Mesorectal Excision in Mid-Low Rectal Cancer: Evaluation of the Learning Curve and Comparison of Short-term Results With Standard Laparoscopic Total Mesorectal Excision.
Zeng Z; Liu Z; Huang L; Liu H; Jie H; Luo S; Zhang X; Kang L
Dis Colon Rectum; 2021 Apr; 64(4):380-388. PubMed ID: 33394779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
